NKGen Biotech, Inc.
NKGN
$0.15
$0.014510.70%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -99.91% | -93.54% | -70.94% | -77.78% | -- |
Total Receivables | -41.46% | -36.11% | -- | -72.92% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -45.83% | 88.15% | -- | 1,076.69% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -28.88% | -21.04% | -- | 7,725.00% | -- |
Total Current Assets | -91.20% | -39.63% | -- | 451.43% | -- |
|
|||||
Total Current Assets | -91.20% | -39.63% | -- | 451.43% | -- |
Net Property, Plant & Equipment | -5.20% | -5.44% | -- | -8.97% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 3.33% | 0.00% | -- | -5.15% | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -40.49% | -25.86% | -- | 0.92% | -- |
|
|||||
Total Accounts Payable | 69.45% | 258.89% | -- | 1,032.31% | -- |
Total Accrued Expenses | -53.29% | 58.56% | -- | 37.64% | -- |
Short-term Debt | 276.60% | 350.27% | -- | -14.28% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 60.42% | -98.92% | -- | -- | -- |
Total Finance Division Other Current Liabilities | -92.76% | 11,354.22% | -- | 19,595.12% | -- |
Total Other Current Liabilities | -92.76% | 11,354.22% | -- | 19,595.12% | -- |
Total Current Liabilities | -4.45% | 121.31% | -- | 167.63% | -- |
|
|||||
Total Current Liabilities | -4.45% | 121.31% | -- | 167.63% | -- |
Long-Term Debt | -27.90% | 1.63% | -- | -- | -- |
Short-term Debt | 276.60% | 350.27% | -- | -14.28% | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 14.33% | 89,396.15% | -- | 99,100.00% | -- |
Total Liabilities | -5.76% | 155.12% | -- | 409.07% | -- |
|
|||||
Common Stock & APIC | 7.78% | 50.12% | -- | 50.77% | -- |
Retained Earnings | -9.64% | -92.56% | -- | -104.77% | -- |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -15.78% | -464.24% | -3,622.39% | -3,855.15% | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -15.78% | -464.24% | -3,622.39% | -3,855.15% | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -15.78% | -464.24% | -3,622.39% | -3,855.15% | -- |
|